High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$40.0M
$39,999,780
Total Sells (Filtered)
$7.7M
$7,719,378
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-09 | $704,657 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-09 | $139,336 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-06 | $14,466 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-06 | $71,572 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-05 | $33,464 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-05 | $6,769 | M | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
Other
2026-03-04
$61,774
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-04 | $61,774 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
2026-03-04
$301,920
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
|
2026-03-04 | $301,920 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-04 | $54,062 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-04 | $9,971 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $49,289 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2026-03-04 | $11,229 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2026-03-03 | $48,858 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-03-03 | $81,734 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-03 | $758 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-03
$3,690
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-03 | $3,690 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2026-03-03 | $27,734 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2026-03-03 | $23,637 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-03 | $246,910 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-03-03 | $234,159 | S | Form 4 |
|
BCAX
P
Bicara Therapeutics Inc.
RA CAPITAL MANAGEMENT, L.P.
• Director
Discretionary Buy
2026-02-26
$4,800,000Large
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Director
Discretionary Buy
|
2026-02-26 | $4,800,000Large | P | Form 4 |
|
BCAX
P
Bicara Therapeutics Inc.
RA CAPITAL MANAGEMENT, L.P.
• Director
Discretionary Buy
2026-02-26
$35,199,780MEGA
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Director
Discretionary Buy
|
2026-02-26 | $35,199,780MEGA | P | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-02-25 | $56,067 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2026-02-25 | $11,779 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-02-25 | $9,435 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2026-01-22 | $7,132 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-01-22 | $34,162 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-01-22 | $69,296 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-01-15 | $2,685 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-12-22 | $34,866 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-12-22 | $168,492 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2025-12-16 | $160,884 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-12-15 | $84,077 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-12-15 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-12-15 | $149,470 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.5%
2025-11-25
$86,562
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.5%
|
2025-11-25 | $86,562 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-25
$17,071
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-25 | $17,071 | S | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
Other
2025-11-25
$17,410
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2025-11-25 | $17,410 | M | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
Other
2025-11-25
$3,434
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2025-11-25 | $3,434 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-11-24 | $776,429 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-11-24 | $67,439 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 SellΔOwn -10.9%
|
2025-11-24 | $330,094 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2025-11-24 | $156,000 | M | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
Other
2025-11-24
$20,844
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2025-11-24 | $20,844 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -13.4%
2025-11-24
$101,475
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -13.4%
|
2025-11-24 | $101,475 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-11-21 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-11-21 | $144,376 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-11-21 | $81,212 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-11-21 | $2,293 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-11-21 | $10,981 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-16 | $453,761 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2025-10-16 | $91,346 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2025-10-15 | $50,363 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $250,391 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-10-15 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-15 | $145,243 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-15 | $81,699 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2025-10-13 | $43,374 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $216,545 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-09 | $116,931 | S | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
Other
2025-10-09
$83,376
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-09 | $83,376 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -38.3%
2025-10-09
$405,900
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -38.3%
|
2025-10-09 | $405,900 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-10-09 | $24,312 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-10-08 | $21,325 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-08 | $102,456 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 SellΔOwn -11.2%
|
2025-10-07 | $332,386 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-10-07 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-07 | $144,473 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-07 | $52,371 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-10-07 | $69,141 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-10-06 | $90,955 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-06 | $433,332 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-06 | $281,666 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2025-10-06 | $24,687 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-06 | $118,356 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Meisner Lara
• Officer • Chief Legal Officer
10b5-1 Sell
2025-09-29
$498,653
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-09-29 | $498,653 | S | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Meisner Lara
• Officer • Chief Legal Officer
Other
2025-09-29
$312,495
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Legal Officer
Other
|
2025-09-29 | $312,495 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Meisner Lara
• Officer • Chief Legal Officer
10b5-1 Sell
2025-09-15
$181,875
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-09-15 | $181,875 | S | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Meisner Lara
• Officer • Chief Legal Officer
Other
2025-09-15
$86,268
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Legal Officer
Other
|
2025-09-15 | $86,268 | M | Form 4 |